Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 ...

Bill Williams, AAPS, compares KinetiSol and spray drying for amorphous solid dispersions, covering 75% drug loading, pill ...

Pauric Bannigan, Intrepid Labs, explains how physics-informed machine learning aids formulation and why regulators still want ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.

Sanjay Konagurthu, PhD, senior director of Science and Innovation at Thermo Fisher Scientific, spoke with PharmTech at AAPS ...

PharmTech spoke with Pauric Bannigan, chief scientific officer and co-founder, Intrepid Labs, at AAPS PharmSci 360 2026, ...

Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it ...

This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ...